Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

Author:

Holkova Beata12,Kmieciak Maciej1,Bose Prithviraj3,Yazbeck Victor Y.12,Barr Paul M.4,Tombes Mary Beth1,Shrader Ellen1,Weir-Wiggins Caryn1,Rollins April D.1,Cebula Erin M.4,Pierce Emily4,Herr Megan4,Sankala Heidi1,Hogan Kevin T.1,Wan Wen5,Feng Changyong46,Peterson Derick R.6,Fisher Richard I.7,Grant Steven128910,Friedberg Jonathan W.411

Affiliation:

1. Massey Cancer Center and Virginia Commonwealth University, Richmond, VA, USA,

2. Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA,

3. University of Texas MD Anderson Cancer Center, Houston, TX, USA,

4. James P. Wilmot Cancer Center, University of Rochester, Rochester, NY, USA,

5. Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, USA,

6. Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA,

7. Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA,

8. Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA,

9. Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA,

10. The Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, VA, USA, and

11. Department of Medicine, University of Rochester, Rochester, NY, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3